3243-40-1 Usage
General Description
3-(4-propoxyphenyl)propionic acid, also known as ethenzamide, is a chemical compound with the molecular formula C12H14O3. It is a nonsteroidal anti-inflammatory drug (NSAID) that is used for its analgesic and anti-inflammatory properties in the treatment of various conditions, including arthritis and menstrual pain. It works by inhibiting the production of inflammatory mediators such as prostaglandins. 3-(4-propoxyphenyl)propionic acid is a white crystalline powder that is soluble in organic solvents and has a melting point of around 96-97°C. It is typically administered orally in the form of tablets or capsules, and its dosage depends on the specific condition being treated. Like other NSAIDs, it may cause side effects such as gastrointestinal irritation and bleeding, so it should be used with caution. Overall, 3-(4-propoxyphenyl)propionic acid is a useful medication for managing pain and inflammation, but it should be used under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 3243-40-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,2,4 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3243-40:
(6*3)+(5*2)+(4*4)+(3*3)+(2*4)+(1*0)=61
61 % 10 = 1
So 3243-40-1 is a valid CAS Registry Number.
3243-40-1Relevant articles and documents
PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS
-
, (2008/12/07)
The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.
INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME
-
Page 90, (2008/06/13)
The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).
